AKUMS DRUGS & PHARMACEUTICALS
Back to Cashflow Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹34 Cr | ₹73 Cr | ₹-108 Cr | ₹125 Cr | ₹236 Cr |
What is the latest Cash Flow from Financing Activities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹34 Cr |
| Mar2025 | ₹73 Cr |
| Mar2024 | ₹-108 Cr |
| Mar2023 | ₹125 Cr |
| Mar2022 | ₹236 Cr |
How is Cash Flow from Financing Activities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹34 Cr | -53.45 | |
| Mar2025 | ₹73 Cr | Positive | |
| Mar2024 | ₹-108 Cr | Negative | |
| Mar2023 | ₹125 Cr | -47.24 | |
| Mar2022 | ₹236 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹11,509.9 Cr | 2.4% | 5.9% | 28% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 2.4% |
5.9% |
28% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses